Societe Generale’s Core Laboratories CLB Stock Holding History

Societe Generale’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$434K	Buy	+3,501	New	+$423K	﹤0.01%	1779

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Societe Generale's CLB Position: Q2 2016 in Review

Societe Generale opened a new position in Core Laboratories (CLB) in Q2 2016: 3,501 shares worth $434K. The stake represents ﹤0.01% of the portfolio and ranks #1779 among its holdings.

383 funds tracked by Wall St. Rank hold CLB as of Q2 2016.

Societe Generale held 3,501 shares of Core Laboratories worth $434K as of Q2 2016.
Core Laboratories was a new Societe Generale position in Q2 2016.
Core Laboratories made up ﹤0.01% of Societe Generale's portfolio in Q2 2016, its #1779 holding.
383 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.